Below are the most recent publications written about "Peroxisome Proliferator-Activated Receptors" by people in Profiles.
-
Williams SD, Smith TM, Stewart LV, Sakwe AM. Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists. Cells. 2022 09 27; 11(19).
-
Khuchua Z, Glukhov AI, Strauss AW, Javadov S. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases. Int J Mol Sci. 2018 Nov 04; 19(11).
-
Huang Y, Powers C, Moore V, Schafer C, Ren M, Phoon CK, James JF, Glukhov AV, Javadov S, Vaz FM, Jefferies JL, Strauss AW, Khuchua Z. The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome. Orphanet J Rare Dis. 2017 03 09; 12(1):49.
-
Irizarry KJL, Chan A, Kettle D, Kezian S, Ma D, Palacios L, Li QQ, Keeler CL, Drechsler Y. Bioinformatics Analysis of Chicken miRNAs Associated with Monocyte to Macrophage Differentiation and Subsequent IFN? Stimulated Activation. Microrna. 2017; 6(1):53-70.
-
Zhao X, Zhang Y, Leander M, Li L, Wang G, Emmett N. Altered expression profile of renal a(1D)-adrenergic receptor in diabetes and its modulation by PPAR agonists. J Diabetes Res. 2014; 2014:725634.
-
Oyekan A. PPARs and their effects on the cardiovascular system. Clin Exp Hypertens. 2011; 33(5):287-93.
-
Thomas K, Sung DY, Chen X, Thompson W, Chen YE, McCarrey J, Walker W, Griswold M. Developmental patterns of PPAR and RXR gene expression during spermatogenesis. Front Biosci (Elite Ed). 2011 06 01; 3(4):1209-20.
-
Guo Q, Wang G, Liu X, Namura S. Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice. Brain Res. 2009 Jul 07; 1279:121-30.
-
Magee TR, Han G, Cherian B, Khorram O, Ross MG, Desai M. Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring. Am J Obstet Gynecol. 2008 Sep; 199(3):271.e1-5.
-
Villacorta L, Garcia-Barrio MT, Chen YE. Transcriptional regulation of peroxisome proliferator-activated receptors and liver X receptors. Curr Atheroscler Rep. 2007 Sep; 9(3):230-7.